P9630
4-Pyridoxic acid
≥98%
Synonym(s):
2-Methyl-3-hydroxy-4-carboxy-5-hydroxymethylpyridine, 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C8H9NO4
CAS Number:
Molecular Weight:
183.16
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
201-440-8
MDL number:
Assay:
≥98%
Form:
powder
Quality Level
assay
≥98%
form
powder
mp
258-261 °C (dec.) (lit.)
storage temp.
−20°C
SMILES string
Cc1ncc(CO)c(C(O)=O)c1O
InChI
1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)
InChI key
HXACOUQIXZGNBF-UHFFFAOYSA-N
Application
4-Pyridoxic acid is a catabolite of vitamin B6. It has been used as a standard in the clinical spectrometric analysis of metabolites.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 2
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Arve Ulvik et al.
The American journal of clinical nutrition, 95(5), 1072-1078 (2012-04-12)
A negative association between systemic markers of inflammation and plasma vitamin B-6 has been observed in population-based and patient cohorts; however, vitamin B-6 (pyridoxine) treatment has mostly failed to improve inflammatory indexes. We aimed to assess the effect of pyridoxine
Oivind Midttun et al.
Clinical chemistry, 51(7), 1206-1216 (2005-06-25)
Homocysteine, a risk factor of cardiovascular disease, cognitive disorders, and pregnancy complications, exists at a point of metabolic convergence of several B vitamins, including vitamins B(6) and B(2) (riboflavin). Measurement of the various forms of these vitamins may be useful
Antitumour Effects of 4?Pyridoxate Diammine Hydroxy Platinum, a Novel Cisplatin Derivative, Against Malignant Gliomas In?vitro and In?vivo: A Comparison with Cisplatin.
Tokunaga Y, et al.
Pharmacy and Pharmacology Communications, 3(7), 353-356 (1997)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| P9630-100MG | 04061833285633 |
| P9630-25MG | 04061833285640 |